SMITM CAPITAL MARKETS LTD. has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc., entailing a capital commitment of $5 million to fuel MABT’s groundbreaking efforts to combat rabies.
Tag Archive for: investment capital
The company’s new integrated solution helps emerging biotech companies ‘nail the narrative’ when it comes to securing investment capital, talent and clinical trial participants.